High mobility group 1 and 2 proteins bind preferentially to DNA that contains bulky adducts induced by benzo[a]pyrene diol epoxide and N-acetoxy- acetylaminofluorene

Cancer Letters

Volumn 158, Issue 1, 2000, Pages 17-25

  Łanuszewska, Joanna ^a   Widłak, Piotr ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Benzo a pyrene diol epoxide; Damage recognition; DNA adducts; High mobility group proteins; N Acetoxy acetylaminofluorene

Indexed keywords

CELL DNA; CHROMIUM; CISPLATIN; DIHYDROXYBENZO[A]PYRENE OXIDE; DIMETHYL SULFATE; HIGH MOBILITY GROUP PROTEIN; ISOPROTEIN; N ACETOXY N (2 FLUORENYL)ACETAMIDE; OLIGODEOXYNUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA STRUCTURE; LIVER CELL DAMAGE; LIVER PROTECTION; MALE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; ULTRAVIOLET C RADIATION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ACETOXYACETYLAMINOFLUORENE; ALKYLATING AGENTS; ANIMALS; BINDING SITES; BLOTTING, SOUTHERN; CARCINOGENS; DNA ADDUCTS; DNA PROBES; HIGH MOBILITY GROUP PROTEINS; MALE; RATS;

EID: 0034730950     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00517-6     Document Type: Article

References (34)

1. Landsman D., Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays. 15:1993;539-546.
2. Bustin M., Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Progress in Nucleic Acid Res. Mol. Biol. 54:1996;35-100.
3. Zlatanova J., van Holde K. Linker histones versus HMG1/2: a struggle for dominance? Bioessays. 20:1998;584-588.
4. Eastman A. Reevaluation of interaction of cis-(ethylenediammine)platinum (II) with DNA. Biochemistry. 25:1986;3912-3915.
5. Bellon S.F., Coleman J.H., Lippard S.J. unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum (II). Biochemistry. 30:1991;8026-8035.
6. +. Biophys. Chem. 35:1990;179-188.
7. Pil P.M., Lippard S.J. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science. 256:1992;234-237.
8. Ohndorf U.-M., Rould M.A., He Q., Pabo C.O., Lippard S.J. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature. 399:1999;708-712.
9. Bruhn S.L., Pil P.M., Essigmann J.M., Housman D.E., Lippard S.J. Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc. Natl. Acad. Sci. USA. 89:1992;2307-2311.
10. Treiber D.K., Zhai X., Jantzen H.-M., Essigmann J.M. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc. Natl. Acad. Sci. USA. 91:1994;5672-5676.
11. Brown S.J., Kellett P.J., Lippard S.J. Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science. 261:1993;603-605.
12. Zamble D.B., Lippard S.J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem. Sci. 20:1995;435-439.
13. Huang J.-C., Zamble D.B., Reardon J.T., Lippard S.J., Sancar A. HMG-domain proteins specifically inhibit the repair of the major DNA adducts of the anticancer drug cisplatin by human excision nuclease. Proc. Natl. Acad. Sci. USA. 91:1994;10394-10398.
14. Wang J.F., Bashir M., Engelsberg B.N., Witmer C., Rozmiarek H., Billings P.C. High mobility group proteins 1 and 2 recognize chromium-damaged DNA. Carcinogenesis. 18:1997;371-375.
15. Pasheva E.A., Pashev I.G., Favre A. Preferential binding of high mobility group 1 protein to UV-damaged DNA. Role of the COOH-terminal domain. J. Biol. Chem. 273:1998;24730-24736.
16. Kriek E. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo. Cancer Res. 32:1972;2042-2048.
17. Meehan T., Straub K., Calvin M. Benzo[a]pyrene diol epoxide covalently binds to deoxyguanosine and deoxyadenosine in DNA. Nature. 269:1977;725-727.
18. Rzeszowska-Wolny J., Widlak P. Damaged DNA-binding proteins: recognition of N-acetoxyacetylaminofluorene-induced DNA adducts. Acta Biochim. Polon. 46:1999;173-180.
19. Ushay H.M., Tullius T.D., Lippard S.J. Inhibition of the BamHI cleavage and unwinding of pBR322 deoxyribonucleic acid by the antitumor drug cis-dichlorodiammineplatinum(II). Biochemistry. 20:1981;3744-3748.
20. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor. 1989;New York.
21. Spiker S. High-mobility group proteins of wheat. J. Biol. Chem. 259:1984;12007-12013.
22. Hughes E.N., Engelsberg B.N., Billings P.C. Purification of nuclear proteins that bind to cisplatin-damaged DNA: Identity with high mobility group proteins 1 and 2. J. Biol. Chem. 267:1992;13520-13527.
23. Turchi J.J., Li M., Henkels K.M. Cisplatin-DNA binding specificity of calf high-mobility group 1 protein. Biochemistry. 35:1996;2992-3000.
24. Yaneva J., Leuba S.H., van Holde K., Zlatanova J. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA. Proc. Natl. Acad. Sci. USA. 94:1997;13448-13451.
25. Husain I., Griffith J., Sancar A. Thymine dimers bent DNA. Proc. Natl. Acad. Sci. USA. 85:1988;2558-2562.
26. n tract bending and its biological implications. Proc. Natl. Acad. Sci. USA. 88:1991;9072-9076.
27. Ciarrocchi G., Pedrini A.M. Determination of pyrimidine dimer unwinding angle by measurement of DNA electrophoretic mobility. J. Mol. Biol. 155:1982;177-183.
28. Kim J.-K., Choi B.-S. The solution structure of DNA duplex-decamer containing the (6-4) photoproduct of thymidylyl(3′-5′)thymine by NMR and relaxation matrix refinement. Eur. J. Biochem. 228:1995;849-854.
29. Schwartz A., Marrot L., Leng M. The DNA bending by acetylaminofluorene residues and by apurinic sites. J. Mol. Biol. 207:1989;445-450.
30. Drinkwater N.R., Miller J.A., Miller E.C., Yang N.-C. Covalent intercalative binding to DNA in relation to the mutagenicity of hydrocarbon epoxides and N-acetoxy-2-acetylaminofluorene. Cancer Res. 38:1978;3247-3255.
31. 1-DNA after covalent binding of the ultimate carcinogen N-acetoxy-N-2-acetylaminofluorene and its 7-iodo derivative. Chem. Biol. Interact. 28:1979;171-180.
32. Marrot L., Hebert E., Saint-Ruf G., Leng M. Comparison of the reactivity of B-DNA and Z-DNA with two isosteric chemical carcinogens: 2-N, N-acetoxyacetylaminofluorene and 3-N, N-acetoxyacetylamino-4,6-dimethyldipyrido-(1,2-a:3′,2′-d) imidazole. Nucleic Acids Res. 15:1987;5629-5642.
33. Xu R., Mao B., Amin S., Geacintov N.E. Bending and circularization of site-specific and stereoisomeric carcinogen-DNA adducts. Biochemistry. 37:1998;769-778.
34. Xu R., Birke S., Carberry S.E., Geacintov N.E., Swenberg C.E., Harvey R.G. Differences in unwinding of supercoiled DNA induced by the two enantiomers of anti-benzo[a]pyrene diol epoxide. Nucleic Acids Res. 20:1992;6167-6176.